Press Releases
July 27th 2010
Amarantus Therapeutics Obtains European Patent Notice of Allowance Covering Discovery of Lead Protein MANF Read more
June 17th 2010
Amarantus Therapeutics Announces Appointment of Lawrence M. Schwartz, Ph.D., to Scientific Advisory Board Read more
May 24th 2010
Amarantus Therapeutics Appoints Dr. Robert J. Zimmerman as Chief Development Officer
Read more
April 27th 2010
Michael J. Fox Foundation for Parkinson’s Research Awards Grant To Amarantus Therapeutics
Read more
January 7th, 2010
Amarantus Therapeutics Inc. to Present at the OneMedForum 2010 Conference
Read More
December 17th, 2009
Amarantus Therapeutics Announces Key Additions to Scientific Advisory Board
Read More
October 28th, 2009
CNS Protein Therapeutics completes name change to Amarantus Therapeutics, appoints new CEO Martin D. Cleary
Read More
Newsletter
February 26th 2010
Amarantus releases Q1 2010 Newsletter Read more